Mainsail Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Mainsail Asset Management's VRTX Position: Q2 2026 in Review
Mainsail Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 22% in Q2 2026, buying an estimated $44.3K and bringing the position to 556 shares worth $270K. The position accounts for 0.11% of the portfolio, ranked #130.
Mainsail Asset Management first reported a position in VRTX in Q2 2024 and has held it in 7 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Mainsail Asset Management held 556 shares of Vertex Pharmaceuticals worth $270K as of Q2 2026.
- Mainsail Asset Management bought 100 Vertex Pharmaceuticals shares in Q2 2026, an estimated $44.3K.
- Vertex Pharmaceuticals made up 0.11% of Mainsail Asset Management's portfolio in Q2 2026, its #130 holding.
- Mainsail Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Mainsail Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.